Our Bodies, Ourselves, July 1, 2020. In response to the demands of thousands of breast implant patients, the FDA proposed that a black box warning be affixed to all implant packages to inform women and their doctors about the most serious risks of breast implants.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
We can’t ever go to the doctor with our guard down’: Why Black women are 40% more likely to die of breast cancer
Fortune Magazine: June 30, 2020 Black Americans are dying from the COVID-19 pandemic at a disproportionately high rate, and are also much more likely to die from many other health problems. Black women are less likely to develop breast cancer but 40% more likely to die from it than White women. The reasons behind this awful disparity are wide-ranging, and include systemic problems both within healthcare and far beyond it.
Read More »Will MLB’s health and safety plan hold up once baseball returns? It’ll be a tough task.
The Washington Post, June 24, 2020. Major League Baseball’s 2020 operations manual has strict, detailed instructions in the ball park, but Conduct Outside of Club Facilities, “feels vague and potentially problematic,” according to multiple public health experts who reviewed the manual.
Read More »CRS: Congress Can Rein In FDA’s Flexible COVID-19 Vaccine Trial Policies
Inside Health Policy, June 03, 2020. The Congressional Research Service says Congress could rein in FDA’s COVID-19 policies by passing a law, and NCHR explains why that is a good idea.
Read More »Hahn Defends Using Less ‘Robust’ Data During COVID, But Critics Contend It Has Gone Too Far
Informa Pharma Intelligence, June 04, 2020. NCHR asserts that anecdotes are not data sets, this problematic situation can been seen in new drugs for coronavirus.
Read More »